Filing Details
- Accession Number:
- 0001609351-17-000081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-26 16:14:48
- Reporting Period:
- 2017-07-24
- Filing Date:
- 2017-07-26
- Accepted Time:
- 2017-07-26 16:14:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609351 | Spark Therapeutics Inc. | ONCE | Biological Products, (No Disgnostic Substances) (2836) | 462654405 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1673528 | Daniel Faga | 3737 Market Street Suite 1300 Philadelphia PA 19104 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-24 | 3,000 | $37.62 | 3,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-24 | 3,000 | $70.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-07-24 | 3,000 | $0.00 | 3,000 | $37.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 148,000 | 2026-05-01 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2017.
- 25% vests May 2, 2017 and the remainder vests in equal quarterly installments over the following three years.
Billionaire Hedge Funds
